AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2010

View the entire original 990 at ProPublica ↗

Organization
AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 13-6180380)
Tax period
2010-01-01 to 2010-12-31
Filed
2011-10-26
IRS object ID
201122999349300712
Schema version
2010v3.4
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2011-10-26T10:22:00-05:00Timestamp
Tax Period End Date2010-12-31TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1TATE AND TRYONBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line12021 L STREET NW SUITE 400AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20036ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2010-01-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN136180380EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1AMERICAN SOCIETY OF CLINICAL ONCOLOGY INCBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlAMERNameControl
Phone5714831300Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line12318 MILL ROAD NO 800AddressLine1
CityALEXANDRIACity
StateVAState
ZIP Code22314ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NamePAUL AINESName
TitleCPA, CFOTitle
Phone5714831300Phone
Date Signed2011-10-25DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameDEBORAH G KOSNETTName
Phone2022932200Phone
FieldValueIRS element (for citing)
Tax Year2010TaxYear
Build TS2016-03-07 17:11:31ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonALLEN LICHTER MDNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line12318 MILL ROAD NO 800AddressLine1
CityALEXANDRIACity
StateVAState
ZIP Code22314ZIPCode
FieldValueIRS element (for citing)
Gross Receipts92510163GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteWWW.ASCO.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1964YearFormation
State Legal DomicileNYStateLegalDomicile
Activity Or Mission DescriptionASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, PREVENTION AND DELIVERY OF HIGH QUALITY PATIENT CARE.ActivityOrMissionDescription
Nbr Voting Members Governing Body18NbrVotingMembersGoverningBody
Nbr Independent Voting Members16NbrIndependentVotingMembers
Total Nbr Employees304TotalNbrEmployees
Total Nbr Volunteers1200TotalNbrVolunteers
Total Gross UBI8404587TotalGrossUBI
Net Unrelated Business Txbl Income1661960NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year9749125ContributionsGrantsPriorYear
Contributions Grants Current Year8931139ContributionsGrantsCurrentYear
Program Service Revenue Prior Year66377111ProgramServiceRevenuePriorYear
Program Service Revenue CY70399472ProgramServiceRevenueCY
Investment Income Prior Year-1105029InvestmentIncomePriorYear
Investment Income Current Year761935InvestmentIncomeCurrentYear
Other Revenue Prior Year-72501OtherRevenuePriorYear
Other Revenue Current Year-537553OtherRevenueCurrentYear
Total Revenue Prior Year74948706TotalRevenuePriorYear
Total Revenue Current Year79554993TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year1594664GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY1766751GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year25300083SalariesEtcPriorYear
Salaries Etc Current Year26424110SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year45000TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY193150TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year2737748TotalFundrsngExpCurrentYear
Other Expense Prior Year43160135OtherExpensePriorYear
Other Expenses Current Year41452554OtherExpensesCurrentYear
Total Expenses Prior Year70099882TotalExpensesPriorYear
Total Expenses Current Year69836565TotalExpensesCurrentYear
Revenues Less Expenses Prior Year4848824RevenuesLessExpensesPriorYear
Revenues Less Expenses CY9718428RevenuesLessExpensesCY
Total Assets BOY140004159TotalAssetsBOY
Total Assets EOY157835906TotalAssetsEOY
Total Liabilities BOY90434447TotalLiabilitiesBOY
Total Liabilities EOY93957853TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY49569712NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY63878053NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionGOAL STATEMENTS: ADVANCE THE EDUCATION OF THE ONCOLOGY COMMUNITY. ADVOCATE PUBLIC POLICY TO ENSURE PATIENTS THE BENEFITS OF ONGOING RESEARCH AND HIGH QUALITY CARE AND ASSIST ONCOLOGISTS GLOBALLY IN OFFERING CANCER PATIENTS THE BEST POSSIBLE OUTCOMES. ASCO VISION STATEMENTS:-- ALL CANCER PATIENTS WILL HAVE LIFELONG ACCESS TO HIGH QUALITY, EFFECTIVE, AFFORDABLE AND COMPASSIONATE CARE.-- THE MOST ACCURATE CANCER INFORMATION WILL BE AVAILABLE SO THAT PATIENTS AND PHYSICIANS CAN MAKE INFORMED DECISIONS ABOUT CANCER PREVENTION AND TREATMENT.-- INFORMATION WE LEARN FROM EVERY PATIENT WILL BE USED TO ACCELERATE PROGRESS AGAINST CANCER.-- RESOURCES WILL EXIST TO ATTRACT THE BEST CLINICIANS AND INVESTIGATORS TO PROVIDE OPTIMAL PATIENT CARE AND TO CONDUCT TRANSFORMATIVE RESEARCH. --ASCO WILL BE RECOGNIZED AS THE MOST TRUSTED SOURCE OF CANCER INFORMATION WORLDWIDE.MissionDescription
Significant New Program Services1SignificantNewProgramServices
Significant Change0SignificantChange
Expense31837975Expense
Grants461163Grants
Revenue36140116Revenue
DescriptionEDUCATIONAL AND SCIENTIFIC MEETINGS AND PRODUCTS AND PROFESSIONAL DEVELOPMENT: ASCO PROVIDES EDUCATIONAL AND SCIENTIFIC PROGRAMS AND CONTENT ON A WIDE VARIETY OF ONCOLOGY-RELATED TOPICS IN A VARIETY OF DIFFERENT FORMATS. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS AND PRESENTS LIVE MEETINGS ON CUTTING EDGE RESEARCH AND SCIENCE IN THE FIELD OF CLINICAL ONCOLOGY. THE SCIENTIFIC RESEARCH AND EDUCATION PRESENTED AT THE MEETINGS ENHANCE KNOWLEDGE ABOUT CANCER, THUS ADVANCING HIGH-QUALITY CANCER CARE.THE ASCO ANNUAL MEETING IS THE WORLD'S PREMIER EDUCATIONAL AND SCIENTIFIC MEETING IN THE ONCOLOGY COMMUNITY AND THE THEMATIC MEETINGS PRESENTED OR CO-SPONSORED BY ASCO PROVIDE OPPORTUNITIES FOR FOCUSED EDUCATIONAL AND SCIENTIFIC PROGRAMMING ON SPECIFIC TYPES OF CANCERS. ASCO'S EDUCATIONAL AND SCIENTIFIC PROGRAMS SERVE THE DIVERSE NEEDS OF ONCOLOGY PRACTITIONERS WORLDWIDE AND THROUGH THE CONTINUUM OF THEIR CAREERS. APPROPRIATE PROGRAMS ARE PROVIDED FOR ONCOLOGY FELLOWS, JUNIOR FACULTY MEMBERS, ONCOLOGY PROGRAM DIRECTORS, AND OTHERS TO MEET THE CHANGING NEEDS OF PEOPLE LIVING WITH CANCER AND ADDRESS THE MODERN-DAY PRACTICE OF ONCOLOGY. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS, IMPLEMENTS AND EVALUATES CONTINUING MEDICAL EDUCATION (CME) TO SUPPORT THE CONTINUED EDUCATION OF ONCOLOGISTS SO THAT THEY ARE BETTER PREPARED TO MEET THE PREVENTION, DIAGNOSIS AND TREATMENT NEEDS OF THEIR PATIENTS. CURRENTLY, ASCO HOLDS THE STATUS OF ACCREDITATION WITH COMMENDATION FROM THE ACCREDITATION COUNCIL FOR CME FOR ASCO'S CME PROGRAM.ASCO MAKES MUCH OF THE CONTENT FROM ITS MEETINGS AND OTHER EDUCATIONAL AND SCIENTIFIC CONTENT AVAILABLE TO THE GENERAL PUBLIC THROUGH TWO ASCO WEBSITES: WWW.ASCO.ORG AND WWW.CANCER.NET. ADDITIONALLY, ASCO MAKES EDUCATIONAL AND SCIENTIFIC MATERIALS AVAILABLE THROUGH A VARIETY OF CHANNELS, INCLUDING BOOKS, DVDS, VIRTUAL MEETINGS, PODCASTS AND PUBLIC FORUMS. HIGHLIGHTS OF THE 2010 ACTIVITIES INCLUDE: APPROXIMATELY 33,000 PEOPLE ATTENDED THE 2010 ASCO ANNUAL MEETING, INCLUDING PHYSICIANS, NURSES, CAREGIVERS, PATIENTS, AND PATIENT ADVOCATES. MORE THAN HALF OF ATTENDEES AT THE 2010 ASCO ANNUAL MEETING WERE INTERNATIONAL ATTENDEES. THE 2010 ANNUAL MEETING FEATURED OVER 250 EDUCATIONAL AND SCIENTIFIC SESSIONS AND OVER 5,000 ABSTRACTS WERE PRESENTED OR PUBLISHED. OVER 1,000 PRESENTATIONS WERE CAPTURED IN AUDIO AND VIDEO TO BE MADE AVAILABLE ELECTRONICALLY.-- IN 2010, ASCO WAS THE LEAD SPONSOR OF SEVERAL THEMATIC SYMPOSIA FOCUSING ON GENITOURINARY CANCERS, GASTROINTESTINAL CANCERS, BREAST CANCER, AND MOLECULAR MARKERS, COLLECTIVELY DRAWING OVER 7,100 ATTENDEES. THESE THEMATIC SYMPOSIA WERE OPEN TO THE GENERAL PUBLIC. -- IN 2010, ASCO SPONSORED OR CO-SPONSORED OVER 30 EDUCATIONAL AND SCIENTIFIC SYMPOSIA, WORKSHOPS, AND COURSES OUTSIDE THE UNITED STATES ON A WIDE VARIETY OF CANCER-RELATED TOPICS TO IMPROVE ONCOLOGY CARE IN (AND) AROUND THE WORLD. THESE MEETINGS INCLUDE: -- ANNUAL MEETING -- GI SYMPOSIUM -- GU SYMPOSIUM -- BREAST CANCER SYMPOSIUM -- MOLECULAR MARKERS -- BEST OF ASCO BOSTON -- BEST OF ASCO SAN FRANCISCO -- ASCO/AACR METHODS WORKSHOPINTERNATIONAL AFFAIRS MEETINGS AND COURSES -- BEST OF ASCO INTERNATIONAL ( 11) -- JOINT SYMPOSIA (8) -- MULTIDISCIPLINARY CANCER MANAGEMENT COURSES (2) -- ADVANCED CANCER COURSES (3)ASCO PUBLISHES ASCO DAILY NEWS, THE OFFICIAL NEWSPAPER OF THE ASCO ANNUAL MEETING, WHICH IS DISTRIBUTED WITHOUT CHARGE TO ANNUAL MEETING ATTENDEES AND ONLINE WORLDWIDE. ASCO DAILY NEWS INCLUDES COVERAGE OF KEY EDUCATIONAL AND SCIENTIFIC SESSIONS, EDITORIALS BY EXPERTS IN VARIOUS SUBSPECIALTIES, INFORMATION ABOUT ASCO PRODUCTS AND RESOURCES, PROFILES OF GRANT AND AWARD WINNERS, AND COMMENTARY AND TOPICS OF INTEREST TO INTERNATIONAL ATTENDEES AND MEMBERS.Description

Activity2 Activity2

FieldValueIRS element (for citing)
Expense10655169Expense
Grants100000Grants
Revenue23828147Revenue
DescriptionEDUCATIONAL PUBLICATIONS: ASCO PUBLISHES TWO EDUCATIONAL JOURNALS ADDRESSING CLINICAL ONCOLOGY THAT ARE AVAILABLE TO THE PUBLIC. JOURNAL OF CLINICAL ONCOLOGY (JCO) IS A HIGHLY REGARDED, PEER-REVIEWED JOURNAL THAT DISSEMINATES QUALITY ARTICLES ON SIGNIFICANT CLINICAL ONCOLOGY RESEARCH IN PRINT AND ELECTRONIC FORMATS. JCO INCLUDES ORIGINAL REPORTS, SELECTED EDITORIALS, COMMENTARIES, REVIEWS, AND OTHER WORK THAT RELATE TO THE CARE OF PATIENTS WITH CANCER. JCO IS TRANSLATED INTO A NUMBER OF LANGUAGES IN INTERNATIONAL EDITIONS, THEREBY INCREASING ITS USE INTERNATIONALLY.PROGRAM SERVICE ACCOMPLISHMENTS: JOURNAL OF ONCOLOGY PRACTICE (JOP) INCLUDES ORIGINAL RESEARCH, FEATURES ARTICLES, AND COLUMNS ON CLINICAL AND ADMINISTRATIVE MANAGEMENT FOR PRACTICING ONCOLOGISTS, WHICH ARE EDITED BY ONCOLOGISTS.IN 2010, THE JOURNAL OF CLINICAL ONCOLOGY HAD 24,300 ANNUAL SUBSCRIBERS. ADDITIONALLY, THE JCO IMPACT FACTOR INCREASED FOR A FOURTH CONSECUTIVE YEAR, AS REPORTED BY THOMSON REUTERS IN ITS 2009 JOURNAL CITATION REPORT. THE RISE IN THE IMPACT FACTOR OF NEARLY 50% SINCE 2005 IS A REFLECTION OF THE VALUE RESEARCHERS FIND IN JCO CONTENT.Description

Activity3 Activity3

FieldValueIRS element (for citing)
Expense8859900Expense
Grants402989Grants
Revenue31631Revenue
DescriptionCANCER POLICY AND CLINICAL AFFAIRS: ASCO'S CANCER POLICY AND CLINICAL AFFAIRS DEPARTMENT REPRESENTS THE INTERESTS OF PHYSICIANS, RESEARCHERS AND OTHER PROFESSIONALS INVOLVED IN CANCER RESEARCH, CARE AND PREVENTION. THE DEPARTMENT WORKS WITH VOLUNTEER COMMITTEES AND ASCO LEADERS TO SHAPE POLICY, LAW AND REGULATION ON ISSUES OF IMPORTANCE TO ASCO'S MEMBERS. THE DEPARTMENT'S PROGRAMS SPAN A BROAD SPECTRUM OF ISSUES, INCLUDING PATIENT-ORIENTED RESEARCH, CLINICAL PRACTICE, EVIDENCE-BASED GUIDELINES AND TECHNOLOGY ASSESSMENTS, QUALITY ASSESSMENT/IMPROVEMENT, WORKFORCE, DISPARITIES, COST/ACCESS, AND CANCER PREVENTION AND CONTROL. ACTIVITIES INCLUDE DIRECT SUPPORT TO MEMBERS SUCH AS HOTLINES, TOOLS AND LEGAL ANALYSIS, EDUCATIONAL WORKSHOPS AND MATERIALS, LEGAL ANALYSIS, DEVELOPMENT OF FORMAL COMMENTS AND TESTIMONY, ADVOCACY, AND SPECIAL STUDIES ON CRITICAL ISSUES FOR THE CANCER COMMUNITY.CANCER POLICY AND CLINICAL AFFAIRS STAFF INTERACT AND COLLABORATE ON A REGULAR BASIS WITH ASCO STATE AND REGIONAL AFFILIATES, OTHER MEDICAL SPECIALTY AND PROFESSIONAL SOCIETIES, CONGRESS, THE ADMINISTRATION, AND PATIENT ADVOCATE ORGANIZATIONS TO ADVANCE COMMON GOALS RELATED TO CANCER RESEARCH AND QUALITY CARE. PROGRAM SERVICE ACCOMPLISHMENTS: IN 2010, ASCO'S ACTIVITIES INCLUDED EFFORTS IN THE FOLLOWING AREAS:1. NEW GUIDELINES AND ONGOING UPDATES: ASCO NOW HAS 28 PUBLISHED PRACTICE GUIDELINES ADDRESSING A WIDE RANGE OF CANCER TREATMENT, DIAGNOSIS, AND MANAGEMENT ISSUES. AN ADDITIONAL 4 GUIDELINES ARE IN DEVELOPMENT, ALONG WITH 8 UPDATES TO EXISTING GUIDELINES. 2. QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI): A QUALITY ASSESSMENT AND IMPROVEMENT PROGRAM FOR OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY-ONCOLOGY PRACTICES. QOPI PROVIDES A WEB-BASED DATA COLLECTION TOOL THAT ALLOWS PRACTICE STAFF TO 1) REPORT ON VARIOUS CANCER CARE QUALITY MEASURES, 2) RECEIVE ANALYZED DATA ON PRACTICE PERFORMANCE, AND 3) COMPARE PERFORMANCE AGAINST THEIR PEERS FOR DATA-DRIVEN IMPROVEMENT ACTIVITIES. THE PROGRAM IS UNIQUE IN THE CANCER COMMUNITY AND HAS BEEN ACCEPTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE AS A MECHANISM FOR SATISFYING PRACTICE EVALUATION AND IMPROVEMENT REQUIREMENTS FOR MAINTENANCE OF CERTIFICATION. ASCO SUPPORTS A NUMBER OF COLLABORATIVE GROUPS THAT USE QOPI WITHIN THEIR INITIATIVES TO DRIVE THEIR QUALITY IMPROVEMENT EFFORTS. OVER 700 PRACTICES NATIONWIDE, INCLUDING HAWAII, ALASKA, GUAM, AND PUERTO RICO ARE ENROLLED IN THE PROGRAM. 3. ADVANCED CANCER CARE: ASCO PUBLISHED A POSITION PAPER ON COMMUNICATION AND DECISION MAKING FOR PATIENTS WITH ADVANCED CANCER. THE PAPER OUTLINES THE GOALS FOR INDIVIDUALIZED CARE, BARRIERS THAT CURRENTLY LIMIT REALIZATION OF THIS VISION, AND POSSIBLE STRATEGIES TO OVERCOME THESE BARRIERS THAT CAN IMPROVE CARE CONSISTENT WITH THE WISHES OF PATIENTS AND EVIDENCE-BASED MEDICINE. 4. THE STATE/REGIONAL AFFILIATE PROGRAM: THE AFFILIATE PROGRAM WAS CREATED IN 1993 TO BETTER SERVE THE NEEDS OF COMMUNITY ONCOLOGISTS, AND TO FACILITATE ASCO'S OWN ADVOCACY PROGRAMS. THE 47 STATE/REGIONAL AFFILIATES INTERACT WITH ASCO THROUGH THE CLINICAL PRACTICE COMMITTEE (CPC), WHERE EACH SOCIETY HAS A VOTING REPRESENTATIVE CHARGED WITH SERVING AS THE BRIDGE BETWEEN THE SOCIETY AND ASCO. THE MEMBER AFFILIATES HAVE ACCESS TO A NUMBER OF BENEFITS INCLUDING STATE SOCIETY MEMBERSHIP RECRUITMENT AND RETENTION ASSISTANCE, CME ACCREDITATION THROUGH JOINTLY SPONSORED EDUCATIONAL SESSIONS, FEDERAL- AND STATE-LEVEL ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND WEBSITE DEVELOPMENT.5. CODING, REIMBURSEMENT, AND COVERAGE POLICY: ASCO REVIEWS AND FREQUENTLY COMMENTS UPON CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS) POLICIES AND PROGRAMS AFFECTING ONCOLOGY. STAFF AND VOLUNTEERS ALSO ACTIVELY PARTICIPATE IN AMERICAN MEDICAL ASSOCIATION (AMA) PROCESSES FOR DEVELOPMENT OF NEW CPT CODES AND VALUATION OF CODES THROUGH THE AMA/SPECIALTY SOCIETY RELATIVE VALUE SCALE UPDATE COMMITTEE (RUC).Description

Activity Other ActivityOther

FieldValueIRS element (for citing)
Expense3206791Expense
Grants344075Grants
Revenue10574306Revenue
DescriptionMEMBER SERVICES: MEMBER SERVICES WORKS TO SUPPORT ASCO'S MORE THAN 30,000 MEMBERS THROUGH ITS DAILY ACTIVITIES, INCLUDING PROCESSING NEW MEMBERSHIP APPLICATIONS AND MEMBER DUES, PHONE AND E-MAIL COMMUNICATIONS, RESEARCHING AND FULFILLING MEMBER REQUESTS, MAINTAINING THE INTEGRITY OF MEMBER DATA, AND NEW MEMBER RECRUITMENT AND RETENTION EFFORTS.ASCO CONNECTION IS THE QUARTERLY MAGAZINE FOR AND ABOUT MEMBERS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY. IT IS THE PRIMARY SOURCE OF INFORMATION ABOUT ASCO'S PROGRAMS, BENEFITS, AND RESOURCES. TOGETHER WITH ITS COMPANION SOCIAL NETWORKING SITE, ASCOCONNECTION.ORG, ASCO CONNECTION PROMOTES OPPORTUNITIES FOR INTERACTION BETWEEN ASCO AND ITS MEMBERS, AND BETWEEN MEMBERS AND THEIR COLLEAGUES. COMMUNICATIONS AND PATIENT INFORMATION: ASCO PROVIDES THE PUBLIC, INCLUDING PATIENTS, THE MEDIA, LEGISLATORS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS WITH ACCURATE INFORMATION ABOUT CANCER, CANCER CARE, TREATMENT, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY.ASCO HAS A FREE PATIENT EDUCATION WEBSITE, CANCER.NET (WWW.CANCER.NET), AVAILABLE TO THE PUBLIC, INCLUDING PATIENTS, THEIR CAREGIVERS, FAMILY MEMBERS AND FRIENDS, THE MEDIA, LEGISLATORS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS THAT PROVIDES UP-TO-DATE INFORMATION ABOUT CANCER, CANCER CARE, TREATMENT, SURVIVORSHIP, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. THE SITE OFFERS MEDICAL INFORMATION ON MORE THAN 120 TYPES OF CANCER AND RELATED SYNDROMES, CLINICAL TRIALS, MANAGING SIDE EFFECTS, CAREGIVING, AND HOW TO COPE WITH THE EMOTIONAL AND SOCIAL EFFECTS OF LIVING WITH CANCER. IN ADDITION TO ITS WEBSITE CONTENT, ASCO OFFERS PRINTED MATERIALS FOR PATIENTS, SUCH AS: CANCER.NET'S GUIDES TO CANCER (DETAILED GUIDES COVERING SYMPTOMS, RISK FACTORS, DIAGNOSIS, STAGING, TREATMENT, CLINICAL TRIAL RESOURCES, SIDE EFFECTS, AFTER TREATMENT, CURRENT RESEARCH AND QUESTIONS TO ASK THE DOCTOR), ASCO ANSWERS FACT SHEETS (A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC, INCLUDING AN OVERVIEW, AN ILLUSTRATION OF WHERE IT STARTS, HOW IT IS TREATED, TERMS TO KNOW, QUESTIONS TO ASK THE DOCTOR, BOOKLETS ON ADVANCED CANCER CARE PLANNING, MANAGING THE COST OF CANCER CARE, AND CANCER IN OLDER ADULTS.ADDITIONAL RESOURCES AVAILABLE ON CANCER.NETFIND AN ONCOLOGIST DATABASE: A FREE SEARCHABLE DATABASE OF ASCO MEMBERS BY SPECIALTY OR LOCATION FOR THOSE IN NEED OF A SPECIALIST.CANCER ADVANCES: SUMMARIES OF RESEARCH ADVANCES IN CLINICAL ONCOLOGY FROM THE JOURNAL OF CLINICAL ONCOLOGY, ASCO'S ANNUAL MEETINGS, ASCO SYMPOSIA, AND ASCO'S MEET THE EXPERTS EVENTS.WHAT TO KNOW - ASCO'S GUIDELINES: PATIENT-FRIENDLY GUIDES BASED ON ASCO'S CLINICAL PRACTICE GUIDELINES FOR PHYSICIANS.RESEARCH AND MEETINGS: INFORMATION ON ASCO'S CLINICAL CANCER ADVANCES REPORT, ASCO'S ANNUAL MEETINGS AND SYMPOSIA, VIRTUAL LECTURES, AND ASCO'S EXPERT PERSPECTIVE ON CANCER NEWS. MULTIMEDIA: MEDICAL ILLUSTRATIONS, VIDEOS, AND PODCASTS ON TOPICS SUCH AS: CANCER RESEARCH, TREATMENT, AND COPING.EXPERT INFORMATION FROM ASCO: ASCO EXPERTS ANSWER QUESTIONS ABOUT CURRENT TOPICS IN CANCER CARE, TREATMENT, AND RESEARCH.CANCER.NET FEATURE ARTICLES: WEEKLY ARTICLES DESIGNED TO PROVIDE IN-DEPTH INFORMATION ON TOPICS OF INTEREST, AS WELL AS PRACTICAL INFORMATION ON CANCER CARE AND TREATMENT.ASCO CANCER TREATMENT SUMMARY FORMS: PRINTABLE FORMS PATIENTS AND THEIR DOCTORS CAN COMPLETE TO HELP KEEP TRACK OF TREATMENT PLANS AND FOLLOW-UP CARE PLANS.CANCER.NET EN ESPANOL: TRANSLATED CONTENT ON THE TREATMENT OF COMMON CANCER TYPES, MANAGING SIDE EFFECTS, AN INTRODUCTION TO CLINICAL TRIALS, AND ASCO'S GUIDELINES.Description
FieldValueIRS element (for citing)
Total Of Other Program Service Exp3206791TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt344075TotalOfOtherProgramServiceGrnt
Total Of Other Program Service Rev10574306TotalOfOtherProgramServiceRev
Total Program Service Expense54559835TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities1LobbyingActivities
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments0TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities1ReportOtherLiabilities
Report Fin48 Footnote1ReportFin48Footnote
Independent Audit Financial Stmt0IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt1ConsolidatedAuditFinancialStmt
School0School
Foreign Office1ForeignOffice
Foreign Activities1ForeignActivities
More Than5000 K To Organizations1MoreThan5000KToOrganizations
More Than5000 K To Individuals1MoreThan5000KToIndividuals
Professional Fundraising1ProfessionalFundraising
Fundraising Activities0FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations1GrantsToOrganizations
Grants To Individuals1GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds1TaxExemptBonds
Invest Tax Exempt Bonds0InvestTaxExemptBonds
Escrow Account0EscrowAccount
On Behalf Of Issuer0OnBehalfOfIssuer
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity1DisregardedEntity
Related Entity1RelatedEntity
Related Org Controlled Entity1RelatedOrgControlledEntity
Transaction Related Entity1TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org0TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With1096420NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Number Of Employees304NumberOfEmployees
Employment Tax Returns Filed1EmploymentTaxReturnsFiled
Unrelated Business Income1UnrelatedBusinessIncome
Form990-T Filed1Form990-TFiled
Foreign Financial Account1ForeignFinancialAccount
Name Of Foreign CountryBDNameOfForeignCountry
Name Of Foreign CountryCJNameOfForeignCountry
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions0QuidProQuoContributions
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members18NbrVotingGoverningBodyMembers
Number Independent Voting Members16NumberIndependentVotingMembers
Family Or Business Relationship0FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders1MembersOrStockholders
Election Of Board Members1ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other1CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
States Where Copy Of Return Is FiledVAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNYStatesWhereCopyOfReturnIsFiled
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1PAUL AINES CPA CFOBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number5714831300TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line12318 MILL ROAD 800AddressLine1
CityALEXANDRIACity
StateVAState
ZIP Code22314ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (39 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorOfficerOfficerReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationKey EmployeeKeyEmployeeHighest Compensated EmployeeHighestCompensatedEmployee
GEORGE SLEDGE MD 08-10
PRESIDENT (10-11)1.00XX000
MICHAEL LINK MD 10-13
PRESIDENT ELECT (10-11)1.00XX2050000
CLIFFORD HUDIS MD 09-12
TREASURER (10-11)1.00X1500000
JAMES ABBRUZZESE MD
BOARD MEMBER (10-13)1.00XX000
MONICA BERTAGNOLLI MD
BOARD MEMBER (08-11)1.00X000
EDUARDO CAZAP MD
BOARD MEMBER (09-12)1.00X000
SUSAN COHN MD
BOARD MEMBER (09-12)1.00X50000
BRUCE JOHNSON MD
BOARD MEMBER (08-11)1.00X000
ROBERT LANGDON MD
BOARD MEMBER (08-11)1.00X000
LORI PIERCE MD
BOARD MEMBER (10-13)1.00X75000
LYNN SCHUCHTER MD
BOARD MEMBER (09-12)1.00X150000
FRANCES SHEPHERD MD
BOARD MEMBER (10-13)1.00X000
SANDRA SWAIN MD
BOARD MEMBER (08-11)1.00X000
EVERETT VOKES MD
BOARD MEMBER (09-12)1.00X350000
JULIE VOSE MD
BOARD MEMBER (10-13)1.00X000
PETER YU MD
BOARD MEMBER (09-12)1.00X200000
ROBIN ZON
BOARD MEMBER (10-13)1.00X000
DOUGLAS BLAYNEY MD 08-10
PRESIDENT (09-10)1.00X250000
GEORGE SLEDGE MD 08-10
PRESIDENT ELECT (09-10)1.00X000
RICHARD SCHILSKY MD08-10
IMMED PAST PRES (09-10)1.00X02500
DEAN BAJORIN MD
BOARD MEMBER (07-10)1.00X000
ROBERT MILLER MD
BOARD MEMBER (07-10)1.00X250000
KATHLEEN PRITCHARD MD
BOARD MEMBER (07-10)1.00X000
DEBORAH SCHRAG MD
BOARD MEMBER (07-10)1.00X50000
JOEL TEPPER MD
BOARD MEMBER (07-10)1.00X000
ALLEN LICHTER MD
CEO37.50X758456018656
DINA MICHELS ESQ
VICE PRES.,GEN COUNSEL,SEC.37.50X447958031884
PAUL AINES CPA
CFO37.50X265394032122
NANCY DALY MSMPH
EXEC DIRECTOR, CCF37.50194770025874X
JEAN COLVARD
S DIR MEMBER & MEETING SVS37.50210948021666X
DEBORAH KAMIN RNPHD
S DIR CANCER POLICY37.50222989031734X
BERNIE KHOO
S DIR INTEGRATED MEDIA37.50319620032122X
CARA MOLINARI
S DIR EDUCATION37.50154714017305X
THERESA VAN SCHAIK
S DIR JOURNALS37.50162288023318X
SUZANNE BRACH
S DIR MARKETING37.50192514025683X
KRISTIN LUDWIG
S DIR COMMUNICATIONS37.50215504017391X
KAY NOLL
S DIR HUMAN RESOURCES37.50185828019742X
DOUGLAS PYLE
S DIR INT'L AFFAIRS37.50175823028116X
LINDA C SCHMIDT
CANCER POLICY37.50199394014955X
FieldValueIRS element (for citing)
Total Reportable Comp From Org3755450TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs250TotalReportableCompFrmRltdOrgs
Total Other Compensation340568TotalOtherCompensation
Number Individuals GT100 K30NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1CityAddressOfContractor/AddressUS/CityStateAddressOfContractor/AddressUS/StateZIP CodeAddressOfContractor/AddressUS/ZIPCodeDescription Of ServicesDescriptionOfServicesCompensationCompensation
ASTUTE TECHNOLOGY
11718 BOWMEN GREEN DRRESTONVA20190VIDEO RECORDING748727
POLSINELLI SHUGHART PC
1152 15TH STREET NWWASHINGTONDC20005LEGAL318270
BECKSTEIN PRODUCTION LLC
12415 ROUSSEAU TERRACENORTH POTOMACMD20878CREATIVE DEVELOPMENT253950
MCDERMOTT WILL & EMORY LLP
28 STATE STREETBOSTONMA02109LEGAL244009
BRYAN CAVE LLP
PO BOX 503089ST LOUISMO63150LEGAL170444
FieldValueIRS element (for citing)
Number Of Contractors GT100 K11NumberOfContractorsGT100K
Related Organizations8931139RelatedOrganizations
Total Contributions8931139TotalContributions

Program Service Revenue ProgramServiceRevenue (5 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnRelated Or Exempt Function IncomeRelatedOrExemptFunctionIncomeUnrelated Business RevenueUnrelatedBusinessRevenue
EDUCATION MTGS & PROD9000992357650223376707199795
MEMBERSHIP9000991057431610574316
PUBLICATIONS5111901038650610386506
EXHIBITS90009998011439801143
ADVERTISING54180093409149340914

Total Oth Program Service Revenue TotalOthProgramServiceRevenue

FieldValueIRS element (for citing)
Total Revenue Column6720091TotalRevenueColumn
Related Or Exempt Function Income6720091RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Program Service Revenue70399472TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column417115TotalRevenueColumn
Exclusion$417,115ExclusionAmount

Income From Invest Bond Proceeds IncomeFromInvestBondProceeds

FieldValueIRS element (for citing)
Total Revenue Column822TotalRevenueColumn
Exclusion$822ExclusionAmount

Royalties Revenue RoyaltiesRevenue

FieldValueIRS element (for citing)
Total Revenue Column116654TotalRevenueColumn
Exclusion$116,654ExclusionAmount

Gross Rents GrossRents

FieldValueIRS element (for citing)
Real211145Real

Less Rental Expenses LessRentalExpenses

FieldValueIRS element (for citing)
Real1365492Real

Rental Income Or Loss RentalIncomeOrLoss

FieldValueIRS element (for citing)
Real-1154347Real

Net Rental Income Or Loss NetRentalIncomeOrLoss

FieldValueIRS element (for citing)
Total Revenue Column-1154347TotalRevenueColumn
Unrelated Business Revenue-1154347UnrelatedBusinessRevenue

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities11904058Securities
Other29618Other

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Securities11589678Securities

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities314380Securities
Other29618Other

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column343998TotalRevenueColumn
Exclusion$343,998ExclusionAmount

Other Revenue Misc OtherRevenueMisc (2 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnExclusionExclusionAmountUnrelated Business RevenueUnrelatedBusinessRevenue
MAILING LIST511120410190$410,190
OTHER90009989950$71,72518225
FieldValueIRS element (for citing)
Total Other Revenue500140TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column79554993TotalRevenueColumn
Related Or Exempt Function Income60858763RelatedOrExemptFunctionIncome
Unrelated Business Revenue8404587UnrelatedBusinessRevenue
Exclusion$1,360,504ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total1190169Total
Program Services1190169ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

FieldValueIRS element (for citing)
Total124500Total
Program Services124500ProgramServices

Foreign Grants ForeignGrants

FieldValueIRS element (for citing)
Total452082Total
Program Services452082ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total2971818Total
Program Services1196704ProgramServices
Management And General1554470ManagementAndGeneral
Fundraising220644Fundraising

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total18450273Total
Program Services12920142ProgramServices
Management And General3680539ManagementAndGeneral
Fundraising1849592Fundraising

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total1277933Total
Program Services905914ProgramServices
Management And General272615ManagementAndGeneral
Fundraising99404Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total2350040Total
Program Services1689906ProgramServices
Management And General459329ManagementAndGeneral
Fundraising200805Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total1374046Total
Program Services941532ProgramServices
Management And General325718ManagementAndGeneral
Fundraising106796Fundraising

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total662580Total
Program Services391836ProgramServices
Management And General270744ManagementAndGeneral

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total101100Total
Management And General101100ManagementAndGeneral

Fees For Services Lobbying FeesForServicesLobbying

FieldValueIRS element (for citing)
Total148210Total
Program Services148210ProgramServices

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total193150Total
Fundraising193150Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

FieldValueIRS element (for citing)
Total174744Total
Management And General174744ManagementAndGeneral

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total10301696Total
Program Services7411248ProgramServices
Management And General2890448ManagementAndGeneral

Advertising Advertising

FieldValueIRS element (for citing)
Total236836Total
Program Services203407ProgramServices
Management And General33429ManagementAndGeneral

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total728928Total
Program Services470390ProgramServices
Management And General256915ManagementAndGeneral
Fundraising1623Fundraising

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total1828574Total
Program Services1318083ProgramServices
Management And General510491ManagementAndGeneral

Occupancy Occupancy

FieldValueIRS element (for citing)
Total4319675Total
Program Services3219347ProgramServices
Management And General1100328ManagementAndGeneral

Travel Travel

FieldValueIRS element (for citing)
Total2378013Total
Program Services1930871ProgramServices
Management And General435272ManagementAndGeneral
Fundraising11870Fundraising

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total8663009Total
Program Services8193312ProgramServices
Management And General469697ManagementAndGeneral

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total2261936Total
Program Services1695407ProgramServices
Management And General513052ManagementAndGeneral
Fundraising53477Fundraising

Insurance Insurance

FieldValueIRS element (for citing)
Total368932Total
Program Services147081ProgramServices
Management And General221851ManagementAndGeneral

Other Expenses OtherExpenses (5 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneralFundraisingFundraising
UBI TAX14401491440149
PRINTING & PRODUCTION4985927491788367657387
POSTAGE & SHIPPING1876824184541031414
BANK & CC FEES1107017102834378674
TAX UNRELATED TO UBI42677732974697031

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total-558373Total
Program Services448163ProgramServices
Management And General-1006536ManagementAndGeneral

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total69836565Total
Program Services54559835ProgramServices
Management And General12538982ManagementAndGeneral
Fundraising2737748Fundraising

Cash Non Interest Bearing CashNonInterestBearing

FieldValueIRS element (for citing)
BOY300BOY
EOY300EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY8629628BOY
EOY5337194EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY4314452BOY
EOY4349645EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY3399994BOY
EOY3940777EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis66398822LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec7272334LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY60399106BOY
EOY59126488EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY50082017BOY
EOY75988397EOY

Investments Other Securities InvestmentsOtherSecurities

FieldValueIRS element (for citing)
BOY12773000BOY
EOY7274631EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY405662BOY
EOY1818474EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY140004159BOY
EOY157835906EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY3839291BOY
EOY4913286EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY15121696BOY
EOY15358538EOY

Tax Exempt Bond Liabilities TaxExemptBondLiabilities

FieldValueIRS element (for citing)
BOY48050000BOY
EOY48050000EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY23423460BOY
EOY25636029EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY90434447BOY
EOY93957853EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY49569712BOY
EOY63878053EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY49569712BOY
EOY63878053EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY140004159BOY
EOY157835906EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses9718428ReconcilationRevenueExpenses
Reconcilation Other Changes4589913ReconcilationOtherChanges
Info In Schedule O Part XIIXInfoInScheduleOPartXII
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee1AuditCommittee
Financial Statement ConsolidatedXFinancialStatementConsolidated
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Publicly Supported Org509a2XPubliclySupportedOrg509a2

Gifts Grants Contrib Received509 GiftsGrantsContribReceived509

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years10019866CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years2928249CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years9732535CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year9749125CurrentTaxYearMinus1Year
Current Tax Year8931139CurrentTaxYear
Total41360914Total

Gross Receipts From Admissions GrossReceiptsFromAdmissions

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years52328773CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years8421317CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years55457162CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year54860215CurrentTaxYearMinus1Year
Current Tax Year58117275CurrentTaxYear
Total229184742Total

Gross Receipts From Non UBI GrossReceiptsFromNonUBI

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years291953CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years89689CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years257198CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year155397CurrentTaxYearMinus1Year
Current Tax Year235462CurrentTaxYear
Total1029699Total

Total509 Total509

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years62640592CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years11439255CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years65446895CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year64764737CurrentTaxYearMinus1Year
Current Tax Year67283876CurrentTaxYear
Total271575355Total

Amts Recd From Disqual Persons AmtsRecdFromDisqualPersons

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years14233783CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years3589400CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years11825034CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year11459125CurrentTaxYearMinus1Year
Current Tax Year10056139CurrentTaxYear
Total51163481Total

Amts From Subst Contributors AmtsFromSubstContributors

FieldValueIRS element (for citing)
Total0Total

Support From DQ Ps Etc SupportFromDQPsEtc

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years14233783CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years3589400CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years11825034CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year11459125CurrentTaxYearMinus1Year
Current Tax Year10056139CurrentTaxYear
Total51163481Total
FieldValueIRS element (for citing)
Public Support Total509220411874PublicSupportTotal509

Gross Investment Income509 GrossInvestmentIncome509

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years2585211CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years700422CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years2234994CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year1248387CurrentTaxYearMinus1Year
Current Tax Year848971CurrentTaxYear
Total7617985Total

Post1975 UBTI Post1975UBTI

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years3328558CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years1418830CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years1237990CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year1445377CurrentTaxYearMinus1Year
Current Tax Year2794100CurrentTaxYear
Total10224855Total

Investment Income And UBTI InvestmentIncomeAndUBTI

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years5913769CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years2119252CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years3472984CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year2693764CurrentTaxYearMinus1Year
Current Tax Year3643071CurrentTaxYear
Total17842840Total

Other Income509 OtherIncome509

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years1434494CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years661354CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years2444918CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year2303656CurrentTaxYearMinus1Year
Current Tax Year2884051CurrentTaxYear
Total9728473Total

Total Support Total TotalSupportTotal

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years69988855CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years14219861CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years71364797CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year69762157CurrentTaxYearMinus1Year
Current Tax Year73810998CurrentTaxYear
Total299146668Total
FieldValueIRS element (for citing)
Public Support Percentage5090.73680PublicSupportPercentage509
Prior Year Support Percentage0.72370PriorYearSupportPercentage
Investment Income Percentage0.05960InvestmentIncomePercentage
Prior Yr Invest Income Percentage0.06330PriorYrInvestIncomePercentage
Thirty Three Percnt Tests CY509XThirtyThreePercntTestsCY509
General ExplanationSCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: CHANGE IN FISCAL YEAR REPORTING: ASCO'S 2007 REPORTED FIGURES REPRESENT THE FINANCIAL TRANSACTIONS FROM ASCO'S SHORT-YEAR PERIOD OF SEPTEMBER 1 - DECEMBER 31, 2007. THIS SHORT-YEAR REPRESENTS A TRANSITIONAL REPORTING PERIOD FOR ASCO FROM A FISCAL YEAR END OF AUGUST 31ST TO A CALENDAR FISCAL YEAR.GeneralExplanation

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbying

FieldValueIRS element (for citing)
Filing Organizations Totals0FilingOrganizationsTotals

Total Direct Lobbying TotalDirectLobbying

FieldValueIRS element (for citing)
Filing Organizations Totals148210FilingOrganizationsTotals

Total Lobbying Expenditures TotalLobbyingExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals148210FilingOrganizationsTotals

Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals63999451FilingOrganizationsTotals

Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals64147661FilingOrganizationsTotals

Lobbying Nontaxable LobbyingNontaxableAmount

FieldValueIRS element (for citing)
Filing Organizations Totals1000000FilingOrganizationsTotals

Grassroots Nontaxable GrassrootsNontaxableAmount

FieldValueIRS element (for citing)
Filing Organizations Totals250000FilingOrganizationsTotals

Tot Lobbying Grassroot Minus Non Tx TotLobbyingGrassrootMinusNonTx

FieldValueIRS element (for citing)
Filing Organizations Totals0FilingOrganizationsTotals

Tot Lobby Expend Mns Lobbying Nontx TotLobbyExpendMnsLobbyingNontx

FieldValueIRS element (for citing)
Filing Organizations Totals0FilingOrganizationsTotals

Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2

FieldValueIRS element (for citing)
Current Year Minus31000000CurrentYearMinus3
Current Year Minus21000000CurrentYearMinus2
Current Year Minus11000000CurrentYearMinus1
Current Year1000000CurrentYear
Total4000000Total
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmount

Total Lobbying Expenditures2 TotalLobbyingExpenditures2

FieldValueIRS element (for citing)
Current Year Minus320258CurrentYearMinus3
Current Year Minus2181000CurrentYearMinus2
Current Year Minus1152632CurrentYearMinus1
Current Year148210CurrentYear
Total502100Total

Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2

FieldValueIRS element (for citing)
Current Year Minus3250000CurrentYearMinus3
Current Year Minus2250000CurrentYearMinus2
Current Year Minus1250000CurrentYearMinus1
Current Year250000CurrentYear
Total1000000Total
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmount

Grassroots Lobbying Expenditures GrassrootsLobbyingExpenditures

FieldValueIRS element (for citing)
Current Year Minus30CurrentYearMinus3
Current Year Minus20CurrentYearMinus2
Current Year Minus1214CurrentYearMinus1
Current Year0CurrentYear
Total214Total

Schedule D IRS990ScheduleD

Current Year CurrentYear

FieldValueIRS element (for citing)
Beginning Of Year Balance0BeginningOfYearBalance
Grants Or Scholarships0GrantsOrScholarships

Current Year Minus1 Year CurrentYearMinus1Year

FieldValueIRS element (for citing)
Beginning Of Year Balance15916BeginningOfYearBalance
Grants Or Scholarships15916GrantsOrScholarships
FieldValueIRS element (for citing)
Board Designated EOY Balance0.00000BoardDesignatedEOYBalance
Permanent Endowment EOY Balance0.00000PermanentEndowmentEOYBalance
Term Endowment EOY Balance0.00000TermEndowmentEOYBalance

Land Land

FieldValueIRS element (for citing)
Other Cost Or Other Basis7342677OtherCostOrOtherBasis
Book Value7342677BookValue

Buildings Buildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis47944341OtherCostOrOtherBasis
Depreciation2989568Depreciation
Book Value44954773BookValue

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis11111804OtherCostOrOtherBasis
Depreciation4282766Depreciation
Book Value6829038BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings59126488TotalOfBookValueLandBuildings

Other Liabilities OtherLiabilities (3 entries)

DescriptionDescriptionAmountAmount
DUE TO AFFILIATE$1,156,663
LIABILITY UNDER INTEREST RATE SWAP AGREEMENT$8,529,366
TAXABLE BOND PAYABLE$15,950,000
FieldValueIRS element (for citing)
Total Of Amounts25636029TotalOfAmounts
Total Revenue79554993TotalRevenue
Total Expenses69836565TotalExpenses
Excess Or Deficit For Year9718428ExcessOrDeficitForYear
Net Unrealized GL On Investments4589913NetUnrealizedGLOnInvestments
Total Adjustments4589913TotalAdjustments
Excess Or Deficit Per FS14308341ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt85510398TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments4589913NetUnrealizedGainsInvestments
Other Revenues1365492OtherRevenues
Revenue Not Rptd F9905955405RevenueNotRptdF990
Revenue Subtotal79554993RevenueSubtotal
Revenue Not Rptd On Fin Stmt0RevenueNotRptdOnFinStmt
Total Revenue Per Form99079554993TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt71202057TotExpensesEtcAuditedFinclStmt
Other Expenses Included1365492OtherExpensesIncluded
Expenses Not Rptd F9901365492ExpensesNotRptdF990
Expenses Subtotal69836565ExpensesSubtotal
Expenses Not Rptd On Fin Stmt0ExpensesNotRptdOnFinStmt
Total Expenses Per Form99069836565TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (3 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:PART X:THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. AT A MINIMUM, THE 2007 THROUGH 2010 TAX YEARS ARE OPEN FOR EXAMINATION BY TAXING AUTHORITIES.
PART XII, LINE 2D - OTHER ADJUSTMENTS:RENTAL EXPENSE TO PART VIII 1,365,492.
PART XIII, LINE 2D - OTHER ADJUSTMENTS:RENTAL EXPENSE TO PART VIII 1,365,492.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records Maintained1GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (9 entries)

RegionRegionNumber Of OfficesNumberOfOfficesNumber Of EmployeesNumberOfEmployeesType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
NORTH AMERICA00PROGRAM SERVICESLICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. INTERNATIONAL DEVELOPMENT AND EDUCATIONAL AWARD (IDEA), BEST OF ASCO INTERNATIONAL (BOA INT'L)6845
CENTRAL AMERICA AND THE CARIBBEAN00PROGRAM SERVICESINTERNATIONAL DEVELOPMENT AND LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS.11363
EAST ASIA AND THE PACIFIC00PROGRAM SERVICESLICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L86204
RUSSIA AND NEWLY INDEPENDENT STATES00PROGRAM SERVICESLICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. INTERNATIONAL DEVELOPMENT AND EDUCATIONAL AWARD (IDEA)5546
EUROPE00PROGRAM SERVICESLICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L93633
SOUTH AMERICA00PROGRAM SERVICESLICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L, ADVANCED CANCER COURSES, MULTIDISCIPLINARY CANCER MANAGEMENT COURSE74980
SUB-SAHARAN AFRICA00PROGRAM SERVICESLICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L, ADVANCED CANCER COURSES60189
MIDDLE EAST & NORTH AFRICA00PROGRAM SERVICESLICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L, ADVANCED CANCER COURSES, MULTIDISCIPLINARY CANCER MANAGEMENT COURSE43406
SOUTH ASIA00PROGRAM SERVICESLICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD, INTERNATIONAL AWARDS COMMITTEE36301
FieldValueIRS element (for citing)
Subtotal Number Of Employees0SubtotalNumberOfEmployees
Cont Number Of Employees0ContNumberOfEmployees
Total Number Of Employees0TotalNumberOfEmployees
Subtotal Amount Spent382166SubtotalAmountSpent
Cont Amount Spent36301ContAmountSpent
Total Amount Spent418467TotalAmountSpent
No Recipient Over5 KXNoRecipientOver5K

Grants To Orgs Outside US GrantsToOrgsOutsideUS

FieldValueIRS element (for citing)
RegionEUROPERegion
Purpose Of GrantCONTRIBUTION TO JOINT METHODS IN CLINICAL CANCER RESEARCH WORKSHOPPurposeOfGrant
Amount Of Cash Grant33615AmountOfCashGrant
FieldValueIRS element (for citing)
Total Number Of501c3 Orgs0TotalNumberOf501c3Orgs
Total Number Of Other Orgs1TotalNumberOfOtherOrgs

Grants To Ind Outside US GrantsToIndOutsideUS (9 entries)

Type Of AssistanceTypeOfAssistanceRegionRegionNumber Of RecipientsNumberOfRecipientsAmount Of Cash GrantAmountOfCashGrantManner Of Cash DisbursementMannerOfCashDisbursementAmount Of Non Cash AssistanceAmountOfNonCashAssistanceDescription Of Non Cash AssistanceDescriptionOfNonCashAssistanceMethod Of ValuationMethodOfValuation
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDNORTH AMERICA11200CHECK3623TRAVEL COSTBOOK
INTERNATIONAL DEVELOPMENTCENTRAL AMERICA AND THE CARIBBEAN11200CHECK3623TRAVEL COSTBOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDEAST ASIA AND THE PACIFIC78400CHECK25359TRAVEL COSTBOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDRUSSIA AND NEWLY INDEPENDENTS STATES11200CHECK3623TRAVEL COSTBOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDEUROPE33600CHECK10868TRAVEL COSTBOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDSOUTH AMERICA22400CHECK7245TRAVEL COSTBOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDSUB-SAHARAN AFRICA22400CHECK7245TRAVEL COSTBOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDMIDDLE EAST & AFRICA22400CHECK7245TRAVEL COSTBOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDSOUTH ASIA44800CHECK14491TRAVEL COSTBOOK
FieldValueIRS element (for citing)
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Agreement Ref Fundraising0AgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation

Name Of Organization NameOfOrganization

FieldValueIRS element (for citing)
Business Name Line1GRAHAM PELTON CONSULTINGBusinessNameLine1

Address US AddressUS

FieldValueIRS element (for citing)
Address Line139 BEECHWOOD RDAddressLine1
CitySUMMITCity
StateNJState
ZIP Code07901ZIPCode
FieldValueIRS element (for citing)
ActivityFUNDRAISING CONSULTANTActivity
Fundraiser Control Of Funds0FundraiserControlOfFunds
Gross Receipts0GrossReceipts
Amount Retained By Contractor193150AmountRetainedByContractor
Net To Organization-193150NetToOrganization
FieldValueIRS element (for citing)
Total Retained By Contractors193150TotalRetainedByContractors
Total Net To Organization-193150TotalNetToOrganization
Licensed StatesVALicensedStates
Licensed StatesNYLicensedStates

Form990 Schedule G Part IV Form990ScheduleGPartIV

FieldValueIRS element (for citing)
IdentifierEXPLANATION OF FUNDRAISING PAYMENTSIdentifier
Return ReferenceSCHEDULE G, PART I, LINE 2B, COLUMN (V)ReturnReference
ExplanationPAYMENTS TO GRAHAM PELTON AND MERZ GROUP WERE FOR FUNDRAISING SERVICES FOR ASCO'S 501(C)(3) AFFILIATE, CONQUER CANCER FOUNDATION TO DETERMINE FUNDRAISING BEST PRACTICES - NO REVENUE WAS RECEIVED.Explanation

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained1RecordsMaintained

Recipient Table RecipientTable (44 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrant
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS (ASCP)
1321 DUKE STREETALEXANDRIAVA22314520942322501(C)(6)5000CONTRIBUTION
FRIENDS OF CANCER RESEARCH
3299 K ST NWWASHINGTONDC20007521983273501(C)(3)30675CONTRIBUTION
AMERICAN COLLEGE OF SURGEONS
633 NORTH ST CLAIRCHICAGOIL60611362192800501(C)(3)50000CONTRIBUTION
ASSOCIATION OF AMERICAN CANCER INST
MEDICAL ART BLDGPITTSBURGHPA15213237410581501(C)(3)5000CONTRIBUTION
BROOKINGS INSTITUTION
1775 MASSACHUSETTS AVEWASHINGTONDC20036530196577501(C)(3)10000CONTRIBUTION
WASHINGTON STATE MEDICAL ONCOLOGY SOC
113 W 7TH ST STE 205VANCOUVERWA98660562367855501(C)(6)5000CONTRIBUTION
KANSAS SOCIETY CLINICAL ONCOLOGY
9200 INDIAN CREEK PKWY SUITE 300OVERLAND PARKKS62210481160355501(C)(6)5000CONTRIBUTION
WEST VIRGINIA ONCOLOGY SOCIETY
211 MARION SQUARE PO BOX 2990FAIRMONTWV26554262558397501(C)(4)10000CONTRIBUTION
ALABAMA CANCER CONGRESS
8805 N 145TH E AVE STE 203OWASSOOK74055262900861501(C)(6)10000CONTRIBUTION
NORTHERN NEW ENGLAND CLINICAL ONCOLOGY SOCIETY
PO BOX 643 C/O L AUBREYSANDOWNNH03873020445055501(C)(3)5000CONTRIBUTION
DUKE CANCER CENTER
2424 ERWIN RD SUITE 601DURHAMNC27705560532129501(C)(3)25000CONTRIBUTION
PREVENT CANCER FOUNDATION
1600 DUKE ST 500ALEXANDRIAVA22314521429544501(C)(3)11000CONTRIBUTION
CANCERCARE
275 7TH AVENEW YORKNY10001131825919501(C)(3)25500CONTRIBUTION
BREAST CANCER RESEARCH FOUNDATION
654 MADISON AVE 1209NEW YORKNY10021133727250501(C)(3)30000CONTRIBUTION
NATIONAL COALITION FOR CANCER SURVIVORSHIP
1010 WAYNE AVE 770SILVER SPRINGMD20910850357897501(C)(3)75000CONTRIBUTION
KOMEN NAT'L RACE FOR THE CURE
1911 N FORT MYER DR 112ARLINGTONVA22209751835298501(C)(3)50530CONTRIBUTION
ALEXANDRIA OFFICE ON WOMEN
421 KING STALEXANDRIAVA22341541780375501(C)(3)5000CONTRIBUTION
ANIMAL WELFARE LEAGUE OF ALEXANDRIA
4101 EISENHOWER AVENUEALEXANDRIAVA22304540796610501(C)(3)5000CONTRIBUTION
CONQUER CANCER FOUNDATION
2318 MILL ROAD 800ALEXANDRIAVA22314311667995501(C)(3)90568CONTRIBUTION
FRED HUTCHINSON CANCER CENTER
110 FAIRVIEW AVE NSEATTLEWA98109237156071501(C)(3)20900CONTRIBUTION
INTERNATIONAL UNION AGAINST CANCER
500 FIFTH ST NWWASHINGTONDC20001237208844501(C)(3)44380CONTRIBUTION
MEMORIAL SLOAN KETTERING CANCER CENTER
PO BOX 026338NEW YORKNY10087131924236501(C)(3)46037CONTRIBUTION
INDIANA UNIVERSITY
620 UNION DRIVEINDIANAPOLISIN46202356001673501(C)(3)142549CONTRIBUTION
STANFORD UNIVERSITY
1000 WELCH ROAD 301STANFORDCA94301941156365501(C)(3)53631CONTRIBUTION
UNIVERSITY OF MICHIGAN
3003 S STATE STREETANN ARBORMI48109386006309501(C)(3)83200CONTRIBUTION
UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVECHICAGOIL60637362177139501(C)(3)10400CONTRIBUTION
AMERICAN CANCER BIOREPOSITORY INC
201 E JEFFERSON STREETLOUISVILLEKY40202141843303501(C)(3)13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
CANCER CARE ASSOCIATES MEDICAL GROUP INC
514 N PROSPECT AVE 4TH FLREDONDO BEACHCA90277330004735N/A13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
DREYER CANCER CTR
1221 N HIGHLAND AVEAURORAIL60506362690329N/A13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
HEMATOLOGY ONCOLOGY ASSOC IL
676 N ST CLAIRCHICAGOIL60611364117454N/A13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
IOWA CANCER CARE ONCOLOGY ASSOCIATES
525 10TH ST SECEDAR RAPIDSIA52403421203658N/A13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
LOUISIANA ONCOLOGY SOCIETY
501 W ST MARY BLVD SUITE 200LAFAYETTELA70506721188733501(C)(3)6500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
MAINE GENERAL MEDICAL CTR
361 OLD BELGRADE ROADAUGUSTAME04330043369653501(C)(3)13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
NEW YORK HOSP QUEENS
56-26 MAIN STFLUSHINGNY11355112638852501(C)(3)13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
NORTHWEST MEDICAL SPEC PLLC
1624 SOUTH I STREETTACOMAWA98405911867315N/A13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
ONCOLOGY ALLIANCE SC
1055 N MAYFAIR RDWAUWATOSAWI53226391225006N/A13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
PALO ALTO MEDICAL FOUNDATION
795 EL CAMINO REALPALO ALTOCA94301941156581501(C)(3)6500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
PIKEVILLE MEDICAL CENTER INC
911 BYPASS ROADPIKEVILLEKY41501610458376501(C)(3)13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
RAMAN SOOD PHYSICIAN PC
617 CENTRAL AVEDUNKIRKNY14048161059338N/A13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
SIMONDS-SINON REGIONAL
275 NICHOLS ROADFITCHBURGMA01420042103555501(C)(3)13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
SOUTHFIELD ONCOLOGY INST INC
21751 WEST ELEVEN MILE ROADSOUTHFIELDMI48076382851003501(C)(3)13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
THE MIRIAM HOSPITAL
164 SUMMIT AVEPROVIDENCERI02906050258905501(C)(3)13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
WENATCHEE VALLEY MED CTR PS
820 N CHELANWENATCHEEWA98801910647181N/A13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
WEST CLINIC PC
100 N HUMPHREYS BLVDMEMPHISTN38120621526296N/A13500SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants29TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations15TotalNbrOfOtherOrganizations

Form990 Schedule I Part III Form990ScheduleIPartIII (8 entries)

Type Of GrantTypeOfGrantNumber Of RecipientsNumberOfRecipientsAmount Of Cash GrantAmountOfCashGrant
SCIENCE OF ONCOLOGY AWARD110000
DAVID A KARNOFSKY AWARD125000
BJ KENNEDY AWARD15000
PEDIATRIC ONCOLOGY AWARD15000
GIANNI BONADONNA BREAST CANCER AWARD110000
ASCO / AMERICAN CANCER SOCIETY AWARD110000
DIVERSITY IN ONCOLOGY INITIATIVE WHICH INCLUDED 4 MEDICAL STUDENT ROTATION AWARDS AND 16 RESIDENT TRAVEL AWARDS2032500
SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM227000

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS IN THE U.S.:Identifier
Return ReferencePART I, LINE 2:ReturnReference
ExplanationSCHEDULE I, PART I, LINE 2: ASCO GRANTS SEVERAL SPECIAL AWARDS INTENDED TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS WHOSE COMMITMENT TO FURTHERING THE PROGRESS AGAINST CANCER HAS LED TO TREMENDOUS CONTRIBUTIONS TO THE FIELD OF CLINICAL ONCOLOGY, CANCER PATIENTS, AND ASCO. SPECIAL AWARD RECIPIENTS ARE HONORED AT AND MOST GIVE A LECTURE DURING AN ASCO MEETING OR SYMPOSIUM. SPECIAL AWARD RECIPIENTS ARE SELECTED BASED ON A PEER-REVIEW PROCESS USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH AWARD. FUNDS AWARDED TO SPECIAL AWARD RECIPIENTS ARE GIVEN AS STIPENDS OR PRIZES, NOT FOR SPECIFIC RESEARCH PROJECTS THAT ARE SUBJECT TO REPORTING. DUE TO THE TYPE OF AWARD THERE IS NO FOLLOW UP ON THE USE OF THE FUNDS. THE GIANNI BONADONNA BREAST CANCER AWARD, BREAST CANCER REGISTRY PILOT PROGRAM AND THE DIVERSITY IN ONCOLOGY MEDICAL STUDENT ROTATION PROGRAM ARE REQUIRED TO NOTIFY GRANT SUPPORT STAFF IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET SUCH TIME SCHEDULES AS MAY HAVE BEEN PROPOSED. GRANTEES ARE REQUIRED TO NOTIFY THE GRANT SUPPORT STAFF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. THE GRANT SUPPORT STAFF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS FOLLOWING THE END OF THE GRANT BUDGET PERIOD. THE GRANT SUPPORT STAFF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. THE GRANT SUPPORT STAFF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS FOLLOWING EXPIRATION OF THE GRANT. THE GRANT SUPPORT STAFF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED. GRANTS ARE ADMINISTRATIVELY CLOSED BY THE GRANT SUPPORT STAFF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER THE GRANT SUPPORT STAFF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. THE GRANT SUPPORT STAFF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Housing Allowance Or ResidenceXHousingAllowanceOrResidence
Written Policy Re T And E Expenses1WrittenPolicyReTAndEExpenses
Substantiation Required1SubstantiationRequired
Compensation CommitteeXCompensationCommittee
Independent ConsultantXIndependentConsultant
Form990 Of Other OrganizationsXForm990OfOtherOrganizations
Written Employment ContractXWrittenEmploymentContract
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan1SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments1AnyNonFixedPayments
Initial Contract Exception1InitialContractException
Rebuttable Presumption Procedure1RebuttablePresumptionProcedure

Form990 Schedule J Part II Form990ScheduleJPartII (14 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
ALLEN LICHTER MD
606893091563060000000186560777112000
DINA MICHELS ESQ
4452440002714000318840479842000
PAUL AINES CPA
2613940400000000321220297516000
NANCY DALY MSMPH
1947700000000258740220644000
JEAN COLVARD
2079480300000000216660232614000
DEBORAH KAMIN RNPHD
2189890400000000317340254723000
BERNIE KHOO
30562001400000000321220351742000
CARA MOLINARI
1547140000000173050172019000
THERESA VAN SCHAIK
1597880250000000233180185606000
SUZANNE BRACH
1895140300000000256830218197000
KRISTIN LUDWIG
2105040500000000173910232895000
KAY NOLL
1818280400000000197420205570000
DOUGLAS PYLE
1728230300000000281160203939000
LINDA C SCHMIDT
1993940000000149550214349000

Form990 Schedule J Part III Form990ScheduleJPartIII (4 entries)

Return ReferenceReturnReferenceExplanationExplanation
PART I, LINE 1AA HOUSING ALLOWANCE IS PROVIDED TO THE CEO, WHICH IS CONSIDERED PART OF THE CEO'S COMPENSATION AND ADDRESSED IN THE CEO'S WRITTEN EMPLOYMENT CONTRACT. THE HOUSING ALLOWANCE IS TREATED AS TAXABLE COMPENSATION.
PART I, LINE 4BCONTRIBUTIONS TO 457(B) PLAN: ALLEN LICHTER $16,500 JEAN COLVARD $16,500
PART I, LINE 7PERFORMANCE-BASED BONUS PAYMENTS CAN BE MADE TO SOME EMPLOYEES LISTED ON SCHEDULE J AND INCLUDED AS PART OF THE TOTAL COMPENSATION. THE BONUS PAYMENTS ARE NOT ON A FIXED BASIS BUT RATHER ARE BASED ON PERFORMANCE AND DETERMINED BY THE CEO WITH REVIEW AND APPROVAL BY THE COMPENSATION COMMITTEE OF THE BOARD, WHERE APPROPRIATE.
PART I, LINE 8CERTAIN AMOUNTS PAID OR ACCRUED TO THE CEO AND THE VP/GC WERE PURSUANT TO A CONTRACT THAT WAS SUBJECT TO THE INITIAL CONTRACT EXCEPTION DESCRIBED IN TREAS. REGS. SECTION 53.4958-4(A)(3).

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI

Issuer Name IssuerName

FieldValueIRS element (for citing)
Business Name Line1INDUSTRIAL DEVELOPMENT AUTHORITY CITY OF ALEXANDRIABusinessNameLine1
FieldValueIRS element (for citing)
Issuer EIN521381432IssuerEIN
CUSIP Number01530LAD2CUSIPNumber
Date Issued2008-04-23DateIssued
Issue Price48050000IssuePrice
Description Of PurposeBUY/BLDOUT 5 FLS HQ BLDGDescriptionOfPurpose
Defeased0Defeased
On Behalf Of Issuer0OnBehalfOfIssuer
Pool Financing0PoolFinancing

Form990 Schedule K Part II Form990ScheduleKPartII

FieldValueIRS element (for citing)
Total Proceeds48050000TotalProceeds
Issuance Costs From Proceeds60538IssuanceCostsFromProceeds
Capital Expenditures47262589CapitalExpenditures
Amount Unspent787411AmountUnspent
Year Of Subst Completion2008YearOfSubstCompletion
Current Refunding0CurrentRefunding
Advance Refunding0AdvanceRefunding
Final Allocation Made0FinalAllocationMade
Adequate Books And Recds Maintaind1AdequateBooksAndRecdsMaintaind

Form990 Schedule K Part III Form990ScheduleKPartIII

FieldValueIRS element (for citing)
Owning Bond Financed Property0OwningBondFinancedProperty
Any Lease Arrangements0AnyLeaseArrangements
Mngment Cntrct Bond Financd Prprty0MngmentCntrctBondFinancdPrprty
Any Research Agreements0AnyResearchAgreements
Bond Counsel Routinely Engaged1BondCounselRoutinelyEngaged
Post Issuance Compliance Procdrs1PostIssuanceComplianceProcdrs

Form990 Schedule K Part IV Form990ScheduleKPartIV

FieldValueIRS element (for citing)
Form8038 T Filed0Form8038TFiled
Variable Rate Issue1VariableRateIssue
Hedge Identified In Books And Recds1HedgeIdentifiedInBooksAndRecds

Name Of Hedge Provider NameOfHedgeProvider

FieldValueIRS element (for citing)
Business Name Line1DEPFA BANKBusinessNameLine1
FieldValueIRS element (for citing)
Term Of Hedge30.000000000000TermOfHedge
Superintegrated Hedge0SuperintegratedHedge
Hedge Terminated0HedgeTerminated
Gross Proceeds Invested In GIC0GrossProceedsInvestedInGIC
Gross Proceeds Invested0GrossProceedsInvested
Exception To Rebate0ExceptionToRebate

Form990 Schedule K Part V Form990ScheduleKPartV

FieldValueIRS element (for citing)
ExplanationPART IV, QUESTION 3: ASCO HAS AN INTEREST RATE SWAP AGREEMENT WITH DEPFA BANK THROUGH 2038. ASCO MAKES FIXED INTEREST PAYMENTS AT A 3.587% RATE. VARIABLE SWAP PAYMENTS, BASED ON ONE-MONTH LIBOR, RECEIVED FROM THE SWAP COUNTERPARTY ARE USED TO MAKE THE VARIABLE INTEREST PAYMENTS AS THEY COME DUE. THESE INTEREST RATE SWAP AGREEMENTS QUALIFY AS A DERIVATIVE INSTRUMENT AND ARE USED TO MITIGATE THE EFFECT OF INTEREST RATE FLUCTUATIONS.Explanation

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (12 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
NEW PROGRAM SERVICESFORM 990, PART III, LINE 2ASCO'S QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI) IS AN ONCOLOGIST-LED, PRACTICE-BASED QUALITY IMPROVEMENT PROGRAM. NEW IN 2010 IS ASCO'S QOPI CERTIFICATION PROGRAM WHICH BUILDS UPON THE SUCCESS OF QOPI. QOPI CERTIFICATION DEMONSTRATES A COMMITMENT TO EXCELLENCE AND ONGOING QUALITY IMPROVEMENT IN THE HEMATOLOGY-ONCOLOGY OUTPATIENT PRACTICE. THE GOALS OF THE QOPI CERTIFICATION PROGRAM ARE TO: -- PROMOTE HIGH QUALITY CANCER CARE AS DEFINED BY THE CLINICIAN EXPERTS. -- PROVIDE A TRUSTED SOLUTION TO SATISFY EXTERNAL DEMAND FOR QUALITY ACTIVITIES. -- REDUCE REDUNDANT PROGRAMS OR ADMINISTRATIVE BURDENS FOR ONCOLOGY PRACTICES, INCLUDING HEALTH PLAN PROGRAMS. THE QOPI CERTIFICATION PROGRAM IS CARRIED OUT BY A SPECIAL-PURPOSE LIMITED LIABILITY COMPANY LIMITED LIABILITY CORPORATION (LLC), THE INSTITUTE OF CLINICAL EXCELLENCE, THE INSTITUTE OF CLINICAL EXCELLENCE, LLC INCLUDES THE TRADE NAME QOPI CERTIFICATION PROGRAM. THE SOLE MEMBER OF THIS LLC IS ASCO AND THE ACTING MANAGER IS ASCO'S CHIEF EXECUTIVE OFFICER.
FORM 990, PART VI, SECTION A, LINE 1AS OF DECEMBER 31, 2010, THE BOARD OF DIRECTORS OF ASCO INCLUDED 18 MEMBERS WITH VOTING RIGHTS: THE PRESIDENT, PRESIDENT-ELECT, TREASURER, IMMEDIATE PAST-PRESIDENT, AND 14 DIRECTORS. ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS ARE ELECTED BY VOTING MEMBERS OF ASCO AND HAVE THE SAME VOTING RIGHTS. THE CHIEF EXECUTIVE OFFICER (CEO) IS AN EX-OFFICIO, NON-VOTING MEMBER OF THE BOARD OF DIRECTORS. DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. DURING THE REPORTING YEAR, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE WERE: THE PRESIDENT, PRESIDENT-ELECT, TREASURER, IMMEDIATE PAST-PRESIDENT, AND THOSE DIRECTORS SERVING THEIR FINAL YEAR OF THEIR TERM. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF ASCO'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY ASCO'S BYLAWS, WHICH PROVIDE THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH ASCO'S BYLAWS.
FORM 990, PART VI, SECTION A, LINE 6ASCO MEMBERS ARE ELECTED BY THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. THE CATEGORIES OF MEMBERSHIP AND SPECIFIED RIGHTS ARE AS FOLLOWS: 1. ACTIVE MEMBERS. 1.A. ACTIVE MEMBERS ARE EXPERIENCED LICENSED PHYSICIANS OF ANY NATION WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. IN EXCEPTIONAL CASES, OTHER PHYSICIANS WHO HAVE MADE SIGNIFICANT CONTRIBUTIONS TO THE FIELD ARE ELIGIBLE FOR ACTIVE MEMBER STATUS. OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G., EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANKS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER ARE ELIGIBLE FOR ACTIVE MEMBER STATUS. 1.B. RIGHTS OF ACTIVE MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS, SERVE ON ALL COMMITTEES OF ASCO, AND VOTE AND HOLD OFFICE IN ASCO. 2. INTERNATIONAL CORRESPONDING MEMBERS. 2.A. INTERNATIONAL CORRESPONDING MEMBERS ARE EXPERIENCED PHYSICIANS WHO ARE ELIGIBLE TO BE ACTIVE MEMBERS, BUT WHO RESIDE IN A DEVELOPING NATION OR A NATION WITH A LOW PER-CAPITA INCOME, AS DEFINED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. 2.B. RIGHTS OF INTERNATIONAL CORRESPONDING MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS. INTERNATIONAL CORRESPONDING MEMBERS MAY NOT SERVE ON COMMITTEES OF ASCO, AND MAY NOT VOTE OR HOLD OFFICE IN ASCO. 3. ACTIVE-ALLIED MEMBERS. 3.A. ACTIVE-ALLIED MEMBERS ARE OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G., EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANK WHO ARE NOT ELIGIBLE TO BE AN ACTIVE MEMBER AND WHO HAVE A PREDOMINANT INTEREST IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. 3.B. RIGHTS OF ACTIVE-ALLIED MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS AND TO SERVE ON ALL COMMITTEES OF ASCO. ACTIVE-ALLIED MEMBERS MAY NOT VOTE OR HOLD OFFICE IN ASCO. 4. AFFILIATE MEMBERS. 4.A. AFFILIATE MEMBERS ARE ONCOLOGY NURSES, PHYSICIAN ASSISTANTS, AND OTHER HEALTH SPECIALISTS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO THE CARE AND TREATMENT OF PATIENTS WITH NEOPLASTIC DISEASES. MEMBERSHIP IS LIMITED TO THOSE PARAMEDICAL PERSONNEL WHO FUNCTION AS INTEGRAL MEMBERS OF A TEAM OF ONCOLOGISTS RESPONSIBLE FOR THE CARE OF SUCH PATIENTS OR WHO ENGAGE IN THE CONDUCT OF CLINICAL TRIALS. ELECTION TO MEMBERSHIP IS BASED ON EXPERIENCE IN AND CONTRIBUTIONS TO THE FIELD OF ONCOLOGY. ADDITIONALLY, AFFILIATE MEMBER STATUS INCLUDES INDIVIDUALS WHO HOLD LEADERSHIP POSITIONS OR HAVE TAKEN A DISTINGUISHED LEADERSHIP ROLE IN A NATIONALLY OR INTERNATIONALLY RECOGNIZED NOT-FOR-PROFIT, TAX-EXEMPT ORGANIZATION DEDICATED TO CANCER PATIENT ADVOCACY OR SURVIVORSHIP. 4.B. RIGHTS OF AFFILIATE MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS AND SERVE ON ALL COMMITTEES OF ASCO. AFFILIATE MEMBERS MAY NOT VOTE OR HOLD OFFICE IN ASCO. 5. EMERITUS MEMBERS. 5.A. EMERITUS MEMBERS ARE ACTIVE, ACTIVE-ALLIED, INTERNATIONAL CORRESPONDING AND AFFILIATE MEMBERS WHO HAVE REQUESTED EMERITUS STATUS AT AGE 65, UPON RETIREMENT OR EARLIER IF PERMANENTLY DISABLED. 5.B. RIGHTS OF EMERITUS MEMBERS INCLUDE BEING EXEMPT FROM MEMBERSHIP DUES. EMERITUS MEMBERS WHO AT THE TIME OF THE REQUEST WERE ACTIVE MEMBERS RETAIN ALL RIGHTS AND PRIVILEGES OF ACTIVE MEMBER STATUS, EXCEPT THE HOLDING OF OFFICE. EMERITUS MEMBERS WHO WERE PREVIOUSLY ACTIVE-ALLIED, INTERNATIONAL CORRESPONDING OR AFFILIATE MEMBERS RETAIN ALL THE RIGHTS AND PRIVILEGES OF ACTIVE-ALLIED, INTERNATIONAL CORRESPONDING OR AFFILIATE MEMBER STATUS RESPECTIVELY. 6. HONORARY MEMBERS. 6.A. HONORARY MEMBERS ARE INDIVIDUALS WHO HAVE MADE AN OUTSTANDING CONTRIBUTION TO CLINICAL ONCOLOGY WHO ARE DESIGNATED AS AN HONORARY MEMBER BY THE BOARD OF DIRECTORS. 6.B. RIGHTS OF HONORARY MEMBERS INCLUDE HAVING ALL PRIVILEGES OF ACTIVE MEMBERS, EXCEPT THEY MAY NOT HOLD OFFICE AND ARE EXEMPT FROM PAYING MEMBERSHIP DUES. 7. ASSOCIATE MEMBERS. 7.A. ASSOCIATE MEMBERS ARE HEALTH PROFESSIONALS HAVING AN MD, DO, PHD, PHARMD, OR OTHER DOCTORAL DEGREE, WHO ARE PARTICIPATING IN A SUBSPECIALTY TRAINING PROGRAM IN ONCOLOGY OR ANOTHER FIELD THAT WOULD LEAD TO ELIGIBILITY FOR ACTIVE OR ACTIVE-ALLIED MEMBERSHIP. 7.B. RIGHTS OF ASSOCIATE MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS. ASSOCIATE MEMBERS MAY NOT HOLD OFFICE OR VOTE, EXCEPT THAT THEY MAY SERVE AS VOTING MEMBERS OF COMMITTEES OF ASCO.
FORM 990, PART VI, SECTION A, LINE 7AVOTING MEMBERS OF ASCO ELECT ALL 18 VOTING MEMBERS OF THE ASCO BOARD OF DIRECTORS: THE PRESIDENT, PRESIDENT-ELECT, PAST-PRESIDENT, TREASURER, AND 14 DIRECTORS. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: ACTIVE MEMBERS; EMERITUS MEMBERS WHO WERE ACTIVE MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS; AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION B, LINE 11AN ELECTRONIC COPY OF THE ASCO FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS AND WAS DISCUSSED AT A MEETING OF THE BOARD BEFORE IT WAS FILED. THE ASCO FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE CHIEF EXECUTIVE OFFICER, AND THE VICE PRESIDENT AND GENERAL COUNSEL PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12CASCO MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASCO MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. ASCO'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF ASCO WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E., A ASCO DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF AN ASCO COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15COMPENSATION OF CHIEF EXECUTIVE OFFICER (CEO): THE DUTIES OF THE CEO OF ASCO INCLUDE SERVING AS: THE CEO OF ASCO, THE CEO OF ASCO'S NON-PROFIT, 501(C) (3) TAX-EXEMPT AFFILIATE, CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) (FORMERLY KNOWN AS THE ASCO CANCER FOUNDATION); THE PRESIDENT OF INSTITUTE OF CLINICAL EXCELLENCE, LLC (D/B/A QOPI CERTIFICATION PROGRAM); AND THE PRESIDENT OF ASCO LEASING, LLC. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE CEO AND ASCO ADDRESSES COMPENSATION OF THE CEO. THE COMPENSATION OF THE CEO WAS DETERMINED BY THE ASCO BOARD OF DIRECTORS, FOLLOWING THE REVIEW AND RECOMMENDATION OF THE COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE CEO WAS REASONABLE. THE REVIEW, RECOMMENDATION, AND DETERMINATION OF THE CEO'S COMPENSATION BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. COMPENSATION OF CERTAIN OFFICERS AND KEY EMPLOYEES OF ASCO VICE PRESIDENT/ GENERAL COUNSEL: THE COMPENSATION OF THE VICE PRESIDENT/GENERAL COUNSEL (VP/GC) WAS CONSIDERED AND APPROVED BY THE COMPENSATION COMMITTEE, AFTER CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE VP/GC WAS REASONABLE. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE VP/GC AND ASCO ADDRESSES COMPENSATION OF THE VP/GC. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE VP/GC BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. CHIEF FINANCIAL OFFICER (CFO): THE COMPENSATION OF THE CHIEF FINANCIAL OFFICER (CFO) WAS CONSIDERED AND APPROVED BY THE COMPENSATION COMMITTEE, AFTER CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE CFO WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE CFO BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. EXECUTIVE DIRECTOR OF THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) (FORMERLY KNOWN AS THE ASCO CANCER FOUNDATION): THE EXECUTIVE DIRECTOR OF CCF IS AN EMPLOYEE OF ASCO. THE COMPENSATION COMMITTEE CONSIDERED AND APPROVED THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF AFTER RECEIVING THE RECOMMENDATIONS OF THE CEO AND THE ADVICE OF INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY: THE COMPENSATION COMMITTEE CONSIDERED AND APPROVED THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY AFTER RECEIVING THE RECOMMENDATIONS OF THE CEO AND THE ADVICE OF INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY BASED ON THE ABOVE DESCRIBED PROCESS WERE UNDERTAKEN IN 2010.
FORM 990, PART VI, SECTION C, LINE 19ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE, WAS PUBLISHED IN THE JANUARY 20, 2006 EDITION OF JOURNAL OF CLINICAL ONCOLOGY (THE EDITION IS AVAILABLE TO THE PUBLIC FOR FREE), AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S ANNUAL REPORT IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST.
FORM 990, PART VI, SECTION A, LINE 7B:NO DECISIONS OF THE GOVERNING BODY ARE SUBJECT TO APPROVAL BY MEMBERS, STOCKHOLDERS, OR OTHER PERSONS. HOWEVER, THE BYLAWS MAY ONLY BE AMENDED AND DISSOLUTION OF THE CORPORATION MAY ONLY BE APPROVED BY VOTING MEMBERS OF ASCO. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: ACTIVE MEMBERS; EMERITUS MEMBERS WHO WERE ACTIVE MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS; AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION B, LINE 10B:ALTHOUGH ASCO HAS STATE AND REGIONAL AFFILIATES THROUGH ITS STATE AND REGIONAL AFFILIATE PROGRAM, ASCO DOES NOT HAVE THE LEGAL AUTHORITY TO EXERCISE SUPERVISION AND CONTROL OVER THEM AND EACH AFFILIATE IS A SEPARATELY INCORPORATED LEGAL ENTITY THAT IS RESPONSIBLE FOR ITS OWN FISCAL MANAGEMENT. AFFILIATES MAY NOT ACT ON BEHALF OF ASCO AND ARE PROHIBITED FROM ANY ACTION THAT MIGHT IMPLY AN AGENCY RELATIONSHIP. AFFILIATES MAY NOT BIND ASCO TO ANY CONTRACT WITH A THIRD PARTY. ASCO'S STATE AND REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ASSIST STATE AND REGIONAL SOCIETIES IN ADDRESSING THE PRACTICAL ISSUES FACING PHYSICIANS WHO CARE FOR PEOPLE WITH CANCER AND TO FACILITATE AND ENCOURAGE INVOLVEMENT IN ASCO'S PUBLIC POLICY INITIATIVES. EACH AFFILIATE HAS A VOTING REPRESENTATIVE ON THE ASCO CLINICAL PRACTICE COMMITTEE (CPC), WHICH IS INTENDED TO ADDRESS THE INTERESTS OF PRACTICING ONCOLOGISTS, WITH A PARTICULAR FOCUS ON REIMBURSEMENT FOR, ACCESS TO, AND QUALITY OF MEDICAL ONCOLOGY SERVICES. THROUGH PARTICIPATION IN THE CPC, AFFILIATES HAVE A ROLE IN THE DEVELOPMENT OF PUBLIC POLICY POSITIONS AT THE NATIONAL LEVEL AND ASCO RECEIVES INPUT REGARDING STATE AND REGIONAL ISSUES AFFECTING ONCOLOGY. STATE AND REGIONAL SOCIETIES INTERESTED IN BEING AFFILIATES MUST SUBMIT AN APPLICATION TO ASCO THAT, AMONG OTHER THINGS, REQUIRES THEM TO DEMONSTRATE THAT THEY ARE VALIDLY INCORPORATED UNDER STATE LAW, HAVE IN PLACE GOVERNANCE PRACTICES AND PROCEDURES (BYLAWS, OFFICERS, DIRECTORS, ELECTIONS, MEETINGS, AND RESPONSIBLE FISCAL MANAGEMENT) AND HAVE PHYSICIAN MEMBERSHIP REQUIREMENTS THAT ARE CONSISTENT WITH ASCO'S STANDARDS. ASCO PROVIDES STATE AFFILIATES WITH A VARIETY OF ASSISTANCE, INCLUDING ASCO POLICY ANALYSES, ACCESS TO ASCO STAFF ON MATTERS OF INTEREST TO STATE AFFILIATES, AND ASSISTANCE WITH MEDIA AND OUTREACH.
CHANGES IN NET ASSETS OR FUND BALANCES:FORM 990, PART XI, LINE 5:NET UNREALIZED GAINS ON INVESTMENTS: 4,589,913.
FORM 990. PART XII, LINE 2C:THERE HAS BEEN NO CHANGE IN THE PROCESS FROM THE PREVIOUS YEAR. ASCO HAS AN AUDIT COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT REVIEW.

Schedule R IRS990ScheduleR

Form990 Schedule R Part I Form990ScheduleRPartI (2 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEINEINPrimary ActivitiesPrimaryActivitiesLegal Domicile StateLegalDomicileStateTotal IncomeTotalIncomeEOY AssetsEOYAssetsBusiness Name Line1DirectControllingEntityName/BusinessNameLine1
INSTITUTE OF CLINICAL EXCELLENCE LLC
2318 MILL ROADALEXANDRIAVA22314271629211QOPI CERTIFICATION PROGAMVA3163136053AMERICAN SOCIETY OF CLINICAL ONCOLOGY
ASCO LEASING LLC
2318 MILL ROADALEXANDRIAVA22314273378225RENTAL OF 5TH FLOORVA211145289206AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Form990 Schedule R Part II Form990ScheduleRPartII

Name Of Disregarded Entity NameOfDisregardedEntity

FieldValueIRS element (for citing)
Business Name Line1CONQUER CANCER FOUNDATION OF ASCO (CCF)BusinessNameLine1

Address US AddressUS

FieldValueIRS element (for citing)
Address Line12318 MILL ROADAddressLine1
CityALEXANDRIACity
StateVAState
ZIP Code22314ZIPCode
FieldValueIRS element (for citing)
EIN311667995EIN
Primary ActivitiesDEDICATED TO CONQUERING CANCER WORLDWIDE BY FUNDING RESEARCHPrimaryActivities
Legal Domicile StateVALegalDomicileState
Exempt Code Section501 (C)(3)ExemptCodeSection
Public Charity Status509 (A)(1)PublicCharityStatus
Controlled Org1ControlledOrg
FieldValueIRS element (for citing)
Receipt Of Int Ann Rents Royalties1ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org1GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org1GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org1LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org0SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org0PurchaseOfAssetsFromOtherOrg
Exchange Of Assets0ExchangeOfAssets
Rental Of Facilities To Other Orgs1RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs0RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs0PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs1PerformOfServicesByOtherOrgs
Sharing Of Facilities0SharingOfFacilities
Sharing Of Paid Employees1SharingOfPaidEmployees
Reimbursement Paid To Other Org1ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org1ReimbursementPaidByOtherOrg
Other Transfer To Other Org0OtherTransferToOtherOrg
Other Transfer From Other Org0OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (9 entries)

Transaction TypeTransactionTypeAmount InvolvedAmountInvolved
CCF
A211536
CCF
B813607
CCF
C8931139
CCF
E64715398
CCF
I211536
CCF
L2933944
CCF
N2477241
CCF
O489823
CCF
P8966365

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.